Helen Liang, PhD

Helen established FoundersX Ventures in 2016 with the support of the founders circle from Stanford. Bringing over 10 years of product experience in high-tech industry, she leads a high-performing team investing in entrepreneurs defining the future and breaking barriers in enterprise AI, fintech, digital health and biotech with 7 unicorns, multiple home runs and more than 20 portfolio companies valued at over $100M. Helen is featured on WSJ Pro Venture Capital and Business Insider as a pioneering tech VC. She holds a PhD from the University of Wisconsin-Madison and is a member of Harvard HBS PE/VC Class 2022. She is a guest lecturer at Stanford and an invited speaker at TechCrunch. Helen is based in Silicon Valley. Select Investments: SpaceX, Salt Security, Jeeves, Kapital, Universal Quantum, 1910 Genetics, Kernal Bio, Meru Health, Nitra, Alinea Invest, Arintra, Cognito TX, Jericho Security, Linvest21.ai, Solve Intelligence.